Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomePension (IS)Profit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Eastman Chemical (EMN) Shares Outstanding (Weighted Average) (2016 - 2026)

Eastman Chemical (EMN) has disclosed Shares Outstanding (Weighted Average) for 18 consecutive years, with $114.2 million as the latest value for Q1 2026.

  • For Q1 2026, Shares Outstanding (Weighted Average) fell 0.87% year-over-year to $114.2 million; the TTM value through Mar 2026 reached $114.2 million, down 0.87%, while the annual FY2025 figure was $114.7 million, 1.71% down from the prior year.
  • Shares Outstanding (Weighted Average) hit $114.2 million in Q1 2026 for Eastman Chemical, roughly flat from $114.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $129.0 million in Q1 2022 and bottomed at $114.2 million in Q1 2026.
  • Average Shares Outstanding (Weighted Average) over 5 years is $118.7 million, with a median of $117.4 million recorded in 2024.
  • Year-over-year, Shares Outstanding (Weighted Average) fell 10.57% in 2022 and then fell 0.87% in 2026.
  • Eastman Chemical's Shares Outstanding (Weighted Average) stood at $123.5 million in 2022, then fell by 3.97% to $118.6 million in 2023, then dropped by 1.6% to $116.7 million in 2024, then fell by 1.71% to $114.7 million in 2025, then dropped by 0.44% to $114.2 million in 2026.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $114.2 million, $114.7 million, and $114.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.